Enlivex Therapeutics Ltd. announced the appointment of Roger J. Pomerantz, M.D., FACP, to its Board of Directors as Vice Chairman. Dr. Pomerantz is a pharmaceutical and biotech industry veteran who has led scientific, drug and business development functions throughout his stellar career. Dr. Pomerantz has held notable positions in both large pharma and small biotech companies.

He served as Worldwide Head of Licensing and Acquisition and Knowledge Management at Merck &Co., where he led the completion of more than 150 business development transactions, and as Global Head of Infectious Diseases for Johnson &Johnson Pharmaceuticals.